MedTrace Logo

Vestibular Outcomes in Vestibular Schwannoma

NCT03346889 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2024-10-30

No results posted yet for this study

Summary

Previous studies have shown that vertigo is the symptoms that mostly affect quality of life in patients with vestibular schwannoma. There is still limited knowledge as to why some patients with this disorder develop vertigo, while others with the same diagnosis do not. The purpose of this study is to measure symptom-related quality of life and to relate this to objective disease characteristics at baseline.

Conditions

  • Vestibular Schwannoma

Sponsors & Collaborators

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Frederik K Goplen, PhD · Haukeland University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-23
Primary Completion
2019-06-25
Completion
2025-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03346889 on ClinicalTrials.gov